GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PRA Health Sciences Inc (NAS:PRAH) » Definitions » PB Ratio

PRA Health Sciences (PRA Health Sciences) PB Ratio : 6.87 (As of Apr. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is PRA Health Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), PRA Health Sciences's share price is $165.21. PRA Health Sciences's Book Value per Share for the quarter that ended in Mar. 2021 was $24.03. Hence, PRA Health Sciences's PB Ratio of today is 6.87.

The historical rank and industry rank for PRA Health Sciences's PB Ratio or its related term are showing as below:

PRAH' s PB Ratio Range Over the Past 10 Years
Min: 1.89   Med: 5.33   Max: 8.1
Current: 6.98

During the past 9 years, PRA Health Sciences's highest PB Ratio was 8.10. The lowest was 1.89. And the median was 5.33.

PRAH's PB Ratio is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.065 vs PRAH: 6.98

During the past 12 months, PRA Health Sciences's average Book Value Per Share Growth Rate was 28.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.80% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of PRA Health Sciences was 66.00% per year. The lowest was 9.50% per year. And the median was 13.15% per year.

Back to Basics: PB Ratio


PRA Health Sciences PB Ratio Historical Data

The historical data trend for PRA Health Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PRA Health Sciences PB Ratio Chart

PRA Health Sciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio
Get a 7-Day Free Trial Premium Member Only 4.66 6.23 5.75 6.47 5.47

PRA Health Sciences Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.77 5.33 4.91 5.47 6.38

Competitive Comparison of PRA Health Sciences's PB Ratio

For the Diagnostics & Research subindustry, PRA Health Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PRA Health Sciences's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PRA Health Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where PRA Health Sciences's PB Ratio falls into.



PRA Health Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

PRA Health Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2021)
=165.21/24.033
=6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


PRA Health Sciences  (NAS:PRAH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


PRA Health Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of PRA Health Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PRA Health Sciences (PRA Health Sciences) Business Description

Traded in Other Exchanges
N/A
Address
4130 ParkLake Avenue, Suite 400, Raleigh, NC, USA, 27612
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.
Executives
Michael J. Bonello officer: EVP & CFO 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Shannon Colin director, officer: President & CEO PRA INTERNATIONAL 12120 SUNSET HILLS ROAD, SUITE 600 RESTON VA 20190
Christopher L Gaenzle officer: EVP, CAO & General Counsel C/O INC RESEARCH HOLDINGS, INC., 3201 BEECHLEAF COURT, SUITE 600, RALEIGH NC 27604
Glen D. Stettin director C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Alexander George Dickinson director 31542 CATALINA AVE LAGUNA BEACH CA 92651
Jeffrey T Barber director 6501 WESTON PARKWAY, SUITE 200 CARY NC 27513
Matthew P. Young director C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Linda S Grais director 86 ALEJANDRA AVE, ATHERTON CA 94027
James C Momtazee director 2884 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
George R Roberts 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 2800 SAND HILL ROAD, MENLO PARK CA 94025
Kkr Pra Investors Gp Ii Llc 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr Pra Investors L.p. 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr Pra Investors Gp Llc 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr North America Xi Ltd 10 percent owner KOHLBERG KRAVIS ROBERTS & CO. L.P., 9 WEST 57TH STREET, SUITE 4200, NEW YORK NY 10019
Kkr North America Fund Xi L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001

PRA Health Sciences (PRA Health Sciences) Headlines

From GuruFocus

PRA Health Sciences to Report Third Quarter 2020 Earnings

By Marketwired Marketwired 10-08-2020

Pra Health Sciences Inc (PRAH) President & CEO Colin Shannon Sold $624,790 of Shares

By GuruFocus Research GuruFocus Editor 08-17-2020